347 related articles for article (PubMed ID: 30108032)
1. Deprescribing Medications for Chronic Diseases Management in Primary Care Settings: A Systematic Review of Randomized Controlled Trials.
Dills H; Shah K; Messinger-Rapport B; Bradford K; Syed Q
J Am Med Dir Assoc; 2018 Nov; 19(11):923-935.e2. PubMed ID: 30108032
[TBL] [Abstract][Full Text] [Related]
2. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
McIntyre C; McQuillan R; Bell C; Battistella M
Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy.
Omuya H; Nickel C; Wilson P; Chewning B
Int J Pharm Pract; 2023 Jun; 31(4):349-368. PubMed ID: 37155330
[TBL] [Abstract][Full Text] [Related]
4. Impact of Deprescribing Interventions in Older Hospitalised Patients on Prescribing and Clinical Outcomes: A Systematic Review of Randomised Trials.
Thillainadesan J; Gnjidic D; Green S; Hilmer SN
Drugs Aging; 2018 Apr; 35(4):303-319. PubMed ID: 29541966
[TBL] [Abstract][Full Text] [Related]
5. Deprescribing as a Clinical Improvement Focus.
Dharmarajan TS; Choi H; Hossain N; Munasinghe U; Lakhi F; Lourdusamy D; Onuoha S; Murakonda P; Skokowska-Lebelt A; Kanagala M; Russell RO
J Am Med Dir Assoc; 2020 Mar; 21(3):355-360. PubMed ID: 31672564
[TBL] [Abstract][Full Text] [Related]
6. Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis.
Gerardi S; Sperlea D; Levy SO; Bondurant-David K; Dang S; David PM; Lizotte A; Senécal L; Paquette F; Vanier MC
Am J Health Syst Pharm; 2022 Nov; 79(Suppl 4):S128-S135. PubMed ID: 35881917
[TBL] [Abstract][Full Text] [Related]
7. Impact of deprescribing rounds on discharge prescriptions: an interventional trial.
Edey R; Edwards N; Von Sychowski J; Bains A; Spence J; Martinusen D
Int J Clin Pharm; 2019 Feb; 41(1):159-166. PubMed ID: 30478496
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of the evidence for deprescribing interventions among older people living with frailty.
Ibrahim K; Cox NJ; Stevenson JM; Lim S; Fraser SDS; Roberts HC
BMC Geriatr; 2021 Apr; 21(1):258. PubMed ID: 33865310
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Pharmacist-Initiated Deprescribing Interventions in Older People: A Narrative Review of Randomized Controlled Trials.
Nguyen M; Beier MT; Louden DN; Spears D; Gray SL
Sr Care Pharm; 2023 Dec; 38(12):506-523. PubMed ID: 38041222
[No Abstract] [Full Text] [Related]
10. Implementation of Proton Pump Inhibitor Deprescription Protocol in Geriatric Residents.
Avraham O; Biglow M
Ann Pharmacother; 2018 Aug; 52(8):747-753. PubMed ID: 29473423
[TBL] [Abstract][Full Text] [Related]
11. Community-based pharmacists' role in deprescribing: A systematic review.
Bužančić I; Kummer I; Držaić M; Ortner Hadžiabdić M
Br J Clin Pharmacol; 2022 Feb; 88(2):452-463. PubMed ID: 34155673
[TBL] [Abstract][Full Text] [Related]
12. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a Pharmacist-Managed Nonsteroidal Anti-Inflammatory Drugs Deprescribing Program in an Integrated Health Care System.
Rashid R; Chang C; Niu F; Deguzman L; Draves M; Awsare S; Hui R
J Manag Care Spec Pharm; 2020 Jul; 26(7):918-924. PubMed ID: 32584681
[TBL] [Abstract][Full Text] [Related]
14. Deprescribing in primary care in Portugal (DePil17-20): a three-phase observational and experimental study protocol.
Simões PA; Santiago LM; Simões JA
BMJ Open; 2018 Jul; 8(7):e019542. PubMed ID: 30018092
[TBL] [Abstract][Full Text] [Related]
15. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
[TBL] [Abstract][Full Text] [Related]
16. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.
Page AT; Clifford RM; Potter K; Schwartz D; Etherton-Beer CD
Br J Clin Pharmacol; 2016 Sep; 82(3):583-623. PubMed ID: 27077231
[TBL] [Abstract][Full Text] [Related]
17. Deprescribing Interventions among Community-Dwelling Older Adults: A Systematic Review of Economic Evaluations.
Romano S; Figueira D; Teixeira I; Perelman J
Pharmacoeconomics; 2022 Mar; 40(3):269-295. PubMed ID: 34913143
[TBL] [Abstract][Full Text] [Related]
18. Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysis.
Bloomfield HE; Greer N; Linsky AM; Bolduc J; Naidl T; Vardeny O; MacDonald R; McKenzie L; Wilt TJ
J Gen Intern Med; 2020 Nov; 35(11):3323-3332. PubMed ID: 32820421
[TBL] [Abstract][Full Text] [Related]
19. Effects of an interprofessional Quality Circle-Deprescribing Module (QC-DeMo) in Swiss nursing homes: a randomised controlled trial.
Cateau D; Ballabeni P; Niquille A
BMC Geriatr; 2021 May; 21(1):289. PubMed ID: 33933030
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
